Previous studies suggest that gut microbiota is associated with neuropsychiatric
disorders, such as Parkinson’s disease, amyotrophic lateral sclerosis, and depression.
However, whether the composition and diversity of gut microbiota is altered in patients
with Alzheimer’s disease (AD) remains largely unknown. In the present study, we collected
fecal samples from 43 AD patients and 43 age- and gender-matched cognitively normal
controls. 16S ribosomal RNA sequencing technique was used to analyze the microbiota
composition in feces. The composition of gut microbiota was different between the two
groups. Several bacteria taxa in AD patients were different from those in controls at
taxonomic levels, such as Bacteroides, Actinobacteria,
Ruminococcus, Lachnospiraceae, and
Selenomonadales. Our findings suggest that gut microbiota is altered in
AD patients and may be involved in the pathogenesis of AD.
HardyJ, SelkoeDJ
(2002) The amyloid hypothesis of Alzheimer’s disease: Progress
and problems on the road to therapeutics. Science297, 353–356.
4.
KleinHU, BennettDA, De
JagerPL (2016)
The epigenome in Alzheimer’s disease: Current state and approaches for a
new path to gene discovery and understanding disease mechanism.
Acta Neuropathol132, 503–514.
5.
ParasharA, UdayabanuM
(2017) Gut microbiota: Implications in Parkinson’s
disease. Parkinsonism Relat Disord38, 1–7.
6.
JinY, WuS,
ZengZ, FuZ
(2017) Effects of environmental pollutants on gut
microbiota. Environ Pollut222, 1–9.
7.
RiederR, WisniewskiPJ, AldermanBL, CampbellSC
(2017) Microbes and mental health: A review.
Brain Behav Immun66, 9–17.
8.
ZhengP, ZengB,
ZhouC, LiuM,
FangZ, XuX,
ZengL, ChenJ,
FanS, DuX,
ZhangX, YangD,
YangY, MengH,
LiW, MelgiriND, LicinioJ, WeiH,
XieP (2016)
Gut microbiome remodeling induces depressive-like behaviors through a
pathway mediated by the host’s metabolism. Mol
Psychiatry21, 786–796 .
9.
AhmadK (2013)
Identification of common target proteins for multiple neurodegenerative
disorders and reconstruction of disease pathway. Physical Review
B67, 1393–1406.
10.
WangJY, ZhouDH,
LiJ, ZhangM,
DengJ, TangM,
GaoC, LiJ,
LianY, ChenM
(2006) Leisure activity and risk of cognitive impairment:
The Chongqing aging study. Neurology66, 911–913.
11.
LiJ, WangYJ,
ZhangM, XuZQ,
GaoCY, FangCQ,
YanJC, ZhouHD,
Chongqing Ageing Study Group (2011)
Vascular risk factors promote conversion from mild cognitive impairment
to Alzheimer disease. Neurology76, 1485–1491.
12.
BuXL, YaoXQ,
JiaoSS, ZengF,
LiuYH, XiangY,
LiangCR, WangQH,
WangX, CaoHY,
YiX, DengB,
LiuCH, XuJ,
ZhangLL, GaoCY,
XuZQ, ZhangM,
WangL, TanXL,
XuX, ZhouHD,
WangYJ (2015)
A study on the association between infectious burden and Alzheimer’s
disease. Eur J Neurol22, 1519–1525.
13.
AdetutuEM, ThorpeK, BourneS, CaoX,
ShahsavariE, KirbyG,
BallAS (2011)
Phylogenetic diversity of fungal communities in areas accessible and not
accessible to tourists in Naracoorte Caves. Mycologia103, 959–968.
14.
AnderssonAF, LindbergM, JakobssonH, BackhedF, NyrenP,
EngstrandL
(2008) Comparative analysis of human gut microbiota by
barcoded pyrosequencing. PLoS One3, e2836.
15.
HouYP, HeQQ,
OuyangHM, PengHS,
WangQ, LiJ,
LvXF, ZhengYN, LiSC,
LiuHL, YinAH
(2017) Human gut microbiota associated with obesity in
Chinese children and adolescents. Biomed Res Int2017, 7585989.
16.
RogersGB, KeatingDJ, YoungRL, WongML,
LicinioJ, WesselinghS
(2016) From gut dysbiosis to altered brain function and
mental illness: Mechanisms and pathways. Mol Psychiatry21, 738–748.
17.
CryanJF, DinanTG
(2012) Mind-altering microorganisms: The impact of the gut
microbiota on brain and behaviour. Nat Rev Neurosci13, 701–712 .
18.
FungTC, OlsonCA, HsiaoEY
(2017) Interactions between the microbiota, immune and
nervous systems in health and disease. Nat Neurosci20, 145–155.
19.
WongML, InserraA, LewisMD, MastronardiCA, LeongL,
ChooJ, KentishS, XieP,
MorrisonM, WesselinghSL, RogersGB, LicinioJ
(2016) Inflammasome signaling affects anxiety- and
depressive-like behavior and gut microbiome composition. Mol
Psychiatry21, 797–805 .
20.
DistruttiE, O’ReillyJA, McDonaldC, CiprianiS, RengaB,
LynchMA, FiorucciS
(2014) Modulation of intestinal microbiota by the probiotic
VSL#3 resets brain gene expression and ameliorates the age-related deficit in
LTP. PLoS One9, e106503.
21.
ArentsenT, QianY,
GkotzisS, FemeniaT, WangT,
UdekwuK, ForssbergH, Diaz
HeijtzR (2017)
The bacterial peptidoglycan-sensing molecule Pglyrp2 modulates brain
development and behavior. Mol Psychiatry22, 257–266 .
22.
SavignacHM, TramullasM, KielyB,
DinanTG, CryanJF
(2015) Bifidobacteria modulate cognitive processes in an
anxious mouse strain. Behav Brain Res287, 59–72.
23.
ZhangL, WangY,
XiayuX, ShiC,
ChenW, SongN,
FuX, ZhouR,
XuYF, HuangL,
ZhuH, HanY,
QinC (2017)
Altered gut microbiota in a mouse model of Alzheimer’s
disease. J Alzheimers Dis60, 1241–1257.
EmeryDC, ShoemarkDK, BatstoneTE, WaterfallCM, CoghillJA, CerajewskaTL, DaviesM, WestNX,
AllenSJ (2017)
16S rRNA next generation sequencing analysis shows bacteria in
Alzheimer’s post-mortem brain. Front Aging Neurosci9, 195.
32.
LukiwWJ (2016)
Bacteroides fragilis lipopolysaccharide and inflammatory signaling in
Alzheimer’s disease. Front Microbiol7, 1544.
33.
MinterMR, ZhangC,
LeoneV, RingusDL, ZhangX,
Oyler-CastrilloP,
MuschMW, LiaoF,
WardJF, HoltzmanDM, ChangEB, TanziRE, SisodiaSS
(2016) Antibiotic-induced perturbations in gut microbial
diversity influences neuro-inflammation and amyloidosis in a murine model of Alzheimer’s
disease. Sci Rep6, 30028.
34.
MinterMR, HinterleitnerR,
MeiselM, ZhangC,
LeoneV, ZhangX,
Oyler-CastrilloP,
ZhangX, MuschMW, ShenX,
JabriB, ChangEB, TanziRE, SisodiaSS
(2017) Antibiotic-induced perturbations in microbial
diversity during post-natal development alters amyloid pathology in an aged
APPSWE/PS1DeltaE9 murine model of Alzheimer’s disease. Sci
Rep7, 10411.
35.
WangXL, ZengJ,
FengJ, TianYT,
LiuYJ, QiuM,
YanX, YangY,
XiongY, ZhangZH, WangQ,
WangJZ, LiuR
(2014) Helicobacter pylori filtrate impairs spatial learning
and memory in rats and increases beta-amyloid by enhancing expression of
presenilin-2. Front Aging Neurosci6, 66.
HuX, WangT,
JinF (2016)
Alzheimer’s disease and gut microbiota. Sci China
Life Sci59, 1006–1023.
38.
AlkasirR, LiJ,
LiX, JinM,
ZhuB (2017)
Human gut microbiota: The links with dementia
development. Protein Cell8, 90–102.
39.
MuddAT, BerdingK, WangM,
DonovanSM, DilgerRN
(2017) Serum cortisol mediates the relationship between fecal
Ruminococcus and brain N-acetylaspartate in the young pig. Gut
Microbes8, 589–600.
40.
CaiH, CongWN,
JiS, RothmanS, MaudsleyS, MartinB
(2012) Metabolic dysfunction in Alzheimer’s disease and
related neurodegenerative disorders. Curr Alzheimer Res9, 5–17.
41.
ChapmanMR, RobinsonLS, PinknerJS, RothR,
HeuserJ, HammarM, NormarkS, HultgrenSJ
(2002) Role of Escherichia coli curli operons in directing
amyloid fiber formation. Science295, 851–855.
42.
ZhaoY, DuaP,
LukiwWJ (2015)
Microbial sources of amyloid and relevance to amyloidogenesis and
Alzheimer’s Didease (AD). J Alzheimers Dis Parkinsonism5, 177.
